https://www.selleckchem.com/pr....oducts/lipofermata.h
riatrician, should be reinforced to improve design and follow-up of the individualised care plan for older patients with advanced chronic kidney disease. Hemorrhoidal disease (HD) is the most common proctological disease, with an estimated prevalence rate of 4.4%, and a peak in individuals between 45 and 65years of age. This study was done to evaluate whether Lian-Zhi-San (LZS), a clinically used anti-hemorrhoidal ointment could alleviate the inflammatory injury, with its associated changes of inflammatory cytokines and morphology o
Like
Comment
Share
